-
1
-
-
70349779416
-
11C]PE2I in patients with schizophrenia: A positron emission tomography study of dopamine transporter
-
11C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter. J Psychiatr Res. 2009;43:1219-1223.
-
(2009)
J Psychiatr Res.
, vol.43
, pp. 1219-1223
-
-
Arakawa, R.1
Ichimiya, T.2
Ito, H.3
-
2
-
-
0030897476
-
PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease
-
Ginovart N, Lundin A, Farde L, et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain. 1997;120:503-514.
-
(1997)
Brain
, vol.120
, pp. 503-514
-
-
Ginovart, N.1
Lundin, A.2
Farde, L.3
-
3
-
-
0344442712
-
Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR
-
Hurley MJ, Mash DC, Jenner P. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR. Eur J Neurosci. 2003;18:2668-2672.
-
(2003)
Eur J Neurosci
, vol.18
, pp. 2668-2672
-
-
Hurley, M.J.1
Mash, D.C.2
Jenner, P.3
-
4
-
-
13244287886
-
Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity
-
Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry. 2005;57:229-238.
-
(2005)
Biol Psychiatry
, vol.57
, pp. 229-238
-
-
Jucaite, A.1
Fernell, E.2
Halldin, C.3
Forssberg, H.4
Farde, L.5
-
5
-
-
73849108267
-
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism
-
Nakamura K, Sekine Y, Ouchi Y, et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry. 2010;67:59-68.
-
(2010)
Arch Gen Psychiatry
, vol.67
, pp. 59-68
-
-
Nakamura, K.1
Sekine, Y.2
Ouchi, Y.3
-
6
-
-
2342555065
-
Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison
-
Walker Z, Costa DC, Walker RW, et al. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology. 2004;62:1568-1572.
-
(2004)
Neurology
, vol.62
, pp. 1568-1572
-
-
Walker, Z.1
Costa, D.C.2
Walker, R.W.3
-
8
-
-
0030781707
-
Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra
-
Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol. 1997;388:211-227.
-
(1997)
J Comp Neurol.
, vol.388
, pp. 211-227
-
-
Hersch, S.M.1
Yi, H.2
Heilman, C.J.3
Edwards, R.H.4
Levey, A.I.5
-
9
-
-
0030031457
-
The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons
-
Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci. 1996;16:436-447.
-
(1996)
J Neurosci
, vol.16
, pp. 436-447
-
-
Nirenberg, M.J.1
Vaughan, R.A.2
Uhl, G.R.3
Kuhar, M.J.4
Pickel, V.M.5
-
10
-
-
81055125527
-
The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration
-
Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain. 2011;134:3146-3166.
-
(2011)
Brain
, vol.134
, pp. 3146-3166
-
-
Cummings, J.L.1
Henchcliffe, C.2
Schaier, S.3
Simuni, T.4
Waxman, A.5
Kemp, P.6
-
11
-
-
77957100232
-
Molecular imaging of the dopamine transporter
-
Varrone A, Halldin C. Molecular imaging of the dopamine transporter. J Nucl Med. 2010;51:1331-1334.
-
(2010)
J Nucl Med.
, vol.51
, pp. 1331-1334
-
-
Varrone, A.1
Halldin, C.2
-
12
-
-
84861325008
-
New developments of dopaminergic imaging in Parkinson's disease
-
Varrone A, Halldin C. New developments of dopaminergic imaging in Parkinson's disease. Q J Nucl Med Mol Imaging. 2012;56:68-82.
-
(2012)
Q J Nucl Med Mol Imaging
, vol.56
, pp. 68-82
-
-
Varrone, A.1
Halldin, C.2
-
14
-
-
70349123080
-
18F]FE-PE2I, a new dopamine transporter PET radioligand
-
18F]FE-PE2I, a new dopamine transporter PET radioligand. Synapse. 2009;63:871-880.
-
(2009)
Synapse
, vol.63
, pp. 871-880
-
-
Varrone, A.1
Steiger, C.2
Schou, M.3
-
19
-
-
84929484781
-
18F-(E)-N-(3-iodoprop-2-enyl)-2β-carbofluoroethoxy-3β-(4′-methyl-phenyl) nortropane binding to the dopamine transporter in Parkinson disease
-
18F-(E)-N-(3-iodoprop-2-enyl)-2β-carbofluoroethoxy-3β-(4′-methyl-phenyl) nortropane binding to the dopamine transporter in Parkinson disease. J Nucl Med. 2015;56:714-720.
-
(2015)
J Nucl Med.
, vol.56
, pp. 714-720
-
-
Fazio, P.1
Svenningsson, P.2
Forsberg, A.3
-
20
-
-
70350547987
-
Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT
-
Varrone A, Sjoholm N, Eriksson L, Gulyas B, Halldin C, Farde L. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur J Nucl Med Mol Imaging. 2009;36:1639-1650.
-
(2009)
Eur J Nucl Med Mol Imaging
, vol.36
, pp. 1639-1650
-
-
Varrone, A.1
Sjoholm, N.2
Eriksson, L.3
Gulyas, B.4
Halldin, C.5
Farde, L.6
|